Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mrs C A Pearl 28/03/2014 Dr D S Pearl 28/03/2014 24 December 2025 The principal activity of the Company during the financial year was that of private medical consultancy activities. 08964790 2025-03-31 08964790 bus:Director1 2025-03-31 08964790 bus:Director2 2025-03-31 08964790 2024-03-31 08964790 core:CurrentFinancialInstruments 2025-03-31 08964790 core:CurrentFinancialInstruments 2024-03-31 08964790 core:ShareCapital 2025-03-31 08964790 core:ShareCapital 2024-03-31 08964790 core:RetainedEarningsAccumulatedLosses 2025-03-31 08964790 core:RetainedEarningsAccumulatedLosses 2024-03-31 08964790 core:OfficeEquipment 2024-03-31 08964790 core:OfficeEquipment 2025-03-31 08964790 core:CostValuation 2024-03-31 08964790 core:DisposalsRepaymentsInvestments 2025-03-31 08964790 core:CostValuation 2025-03-31 08964790 bus:OrdinaryShareClass1 2025-03-31 08964790 bus:OrdinaryShareClass2 2025-03-31 08964790 2024-04-01 2025-03-31 08964790 bus:FilletedAccounts 2024-04-01 2025-03-31 08964790 bus:SmallEntities 2024-04-01 2025-03-31 08964790 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08964790 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08964790 bus:Director1 2024-04-01 2025-03-31 08964790 bus:Director2 2024-04-01 2025-03-31 08964790 core:OfficeEquipment core:TopRangeValue 2024-04-01 2025-03-31 08964790 2023-04-01 2024-03-31 08964790 core:OfficeEquipment 2024-04-01 2025-03-31 08964790 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 08964790 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 08964790 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 08964790 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08964790 (England and Wales)

PEARL MEDICAL CONSULTANCY LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

PEARL MEDICAL CONSULTANCY LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

PEARL MEDICAL CONSULTANCY LIMITED

BALANCE SHEET

As at 31 March 2025
PEARL MEDICAL CONSULTANCY LIMITED

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 1,043 2,214
Investments 4 0 1
1,043 2,215
Current assets
Debtors 5 14,108 7,007
Cash at bank and in hand 135,991 119,362
150,099 126,369
Creditors: amounts falling due within one year 6 ( 31,371) ( 27,112)
Net current assets 118,728 99,257
Total assets less current liabilities 119,771 101,472
Net assets 119,771 101,472
Capital and reserves
Called-up share capital 7 20 20
Profit and loss account 119,751 101,452
Total shareholders' funds 119,771 101,472

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Pearl Medical Consultancy Limited (registered number: 08964790) were approved and authorised for issue by the Board of Directors on 24 December 2025. They were signed on its behalf by:

Dr D S Pearl
Director
PEARL MEDICAL CONSULTANCY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
PEARL MEDICAL CONSULTANCY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Pearl Medical Consultancy Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Ground Floor Blackbrook Gate 1, Blackbrook Business Park, Taunton, TA1 2PX, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover comprises the fair value of the consideration receivable for the provision of services in the ordinary course of the company's activities. The company recognises revenue when the services have been provided.

Employee benefits

Defined contribution schemes
The company contributes to a director's personal pension scheme. Payments to the scheme are charged as an expense when they are paid.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Office equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Office equipment Total
£ £
Cost
At 01 April 2024 7,069 7,069
At 31 March 2025 7,069 7,069
Accumulated depreciation
At 01 April 2024 4,855 4,855
Charge for the financial year 1,171 1,171
At 31 March 2025 6,026 6,026
Net book value
At 31 March 2025 1,043 1,043
At 31 March 2024 2,214 2,214

4. Fixed asset investments

Other investments Total
£ £
Cost or valuation before impairment
At 01 April 2024 1 1
Disposals ( 1) ( 1)
At 31 March 2025 0 0
Carrying value at 31 March 2025 0 0
Carrying value at 31 March 2024 1 1

The fixed asset investment was disposed of during the year for consideration of £1.

5. Debtors

2025 2024
£ £
Trade debtors 14,108 7,007

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 336 324
Amounts owed to directors 8,067 15,646
Accruals 2,208 2,050
Corporation tax 20,387 8,732
Other taxation and social security 373 360
31,371 27,112

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
10 Ordinary A shares of £ 1.00 each 10 10
10 Ordinary B shares of £ 1.00 each 10 10
20 20